Renowned Speakers

Benedict Benigno

Ovarian Cancer Institute USA

Wassil Nowicky

Ukrainian Anti-Cancer Institute Austria

Jan Lewin

The University of Texas MD Anderson Cancer Center USA

Sang Y Lee

The Pennsylvania State University College of Medicine USA

Hiroshi Osawa

Edogawa Hospital Japan

Niccola Funel

University of Pisa Italy

Recommended Global Nursing Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Euro Oncology Nursing 2017

About Conference

ConferenceSeries Ltd welcomes you to attend the "International Conference on Oncology Nursing” which is going to be held on July 03-04, 2017 at Barcelona, SPAIN which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Oncology Nursing 2017 is a global platform to discuss and learn about Cancer Prognosis, General Issues in Cancer Care, Cancer-Basic and Applied Research, Clinical Oncology & Tumor Specific Cancers, Advances in Cancer Therapy, Companion Diagnostics in oncology, Cancer Immunotherapy & Stem Cell Therapy, Cancer Treatment & Advancements in Cancer Therapies, Drug Discovery & Anti-Cancer Vaccines/drugs, Novel Approaches to Cancer Therapeutics and metabolomics, Breast Cancer & Treatment, Complementary and Alternative Medicine (CAM), Pediatric Oncology, Cancer Pain Management, Supportive Care Services & Lifestyle Connection, Gynecologic Oncology & Endocrine Oncology, Radiation Oncology.

ConferenceSeries Ltd Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.

Why to attend???

With members from around the world focused on learning about Oncology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Oncology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new ways of treatment & care, and receive name recognition at this 3-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Oncology are hallmarks of this conference.

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://oncology.nursingconference.com/europe/sponsors.php

Target Audience:

Scientists, Cancer Researchers, Cancer research Faculty, Medical Colleges, Cancer Associations and Societies, Chemotherapists, Physicians, Nursing Faculty, Business Entrepreneurs, Medical Devices, Manufacturing Companies, Pharmaceutical Companies, Oncologists, Radiologists, Pathologists, Academicians, Research Scholars, Students, Biomedical Companies, Diagnostics Companies.

Scope and Importance:

Nursing in cancer care focuses on patient assessment, education, symptom management, and supportive care. In medical oncology they play an integral role in the administration of antineoplastic agents and are responsible for safe drug handling; evaluation of laboratory data; calculation of drug dosages on the basis of body surface area; insertion of intravenous lines or accessing central venous devices; continuous and time intensive monitoring to address potential adverse reactions or drug interactions; and screening patients for inclusion in available research trials or protocols. In the radiation oncology arena the nurses need to have an understanding of radiobiology and radiation physics. They are also responsible for extensive symptom management, patient education and the submission process for clinical trials or research protocols.

Market Analysis

ConferenceSeries Ltd is overwhelmed to announce the commencement of "International Conference on Oncology Nursing" on July 03-04, 2017 in Barcelona, SPAIN.

The upcoming conference will be organized around the theme "Caring is the Essence of Cancer Nursing".

Scope and Importance:

Why Barcelona, SPAIN?

Barcelona is the capital city of the autonomous community of Catalonia in the kingdom of Spain, as well as the country’s second most populous municipality, with a population of 1.6 million within the city limits. Its urban area extends beyond the administrative city limits with a population of around 4.7 million people, being the sixth most populous urban area in the European Union after Paris, London, Madrid, the Ruhr area and Milan.

Barcelona is one of the world's leading tourist, economic, trade fair and cultural centers, and its influence in commerce, education, entertainment, media, fashion, science, and the arts all contribute to its status as one of the world’s major global cities. In 2008 it was the fourth most economically powerful city by GDP in the European Union and 35th in the world with GDP amounting to €177 billion. In 2012, Barcelona had a GDP of $170 billion; it is leading Spain in both employment rate and GDP per capita change. In 2009 the city was ranked Europe's third and one of the world’s most successful as a city brand. In the same year the city was ranked Europe's fourth best city for business and fastest improving European city, with growth improved by 17% per year. Since 2011 Barcelona is a leading smart city in Europe. Barcelona is a transport hub with the Port of Barcelona being one of Europe's principal seaports and busiest European passenger port, an international airport, which handles above 40 million passengers per year.

Conference Highlights:

General Issues in Oncology Nursing

· Clinical Oncology Nursing

· Cancer Pain Management

· Cancer Immunotherapy & Stem Cell Therapy

· Cancer Prognosis

· Oncology Nursing Practice

· Complementary and Alternative Medicine

· Supportive Care Services & Lifestyle Connection

· Cancer Therapy & Treatment

· Anti-Cancer Vaccines/drugs

· Cancer Prognosis

· Cancer Basic & Applied Research

Target Audience:

· Scientists

· Cancer Researchers

· Cancer research Faculty

· Medical Colleges

· Cancer Associations and Societies

· Chemotherapists

· Physicians

· Nursing Faculty

· Business Entrepreneurs

· Medical Devices Manufacturing Companies

· Pharmaceutical Companies

· Oncologists

· Radiologists

· Pathologists

· Academicians

· Research Scholars

· Students

· Biomedical Companies

· Diagnostics Companies

Why to attend???

A Unique Opportunity for Advertisers and Sponsors at this International event:

http://oncology.nursingconference.com/europe/sponsors.php

Market Analysis Report

Advances in understanding of the immune system are changing the way oncologists treat cancer. In recent years, researchers have increasingly looked to harnessing the patient's immune system in the management of difficult to treat cancers. While such an approach was once felt to be unattainable, a better understanding of how the adaptive immune system works has allowed the field of immuno-oncology to move to the clinic with increasing success. This study's objective was to assess practicing oncologists' familiarity with, and understanding of, immuno-oncology concepts that will play an important role in the care of patients with metastatic cancer such as those with lung cancer. A total of 469 of oncologist have participated in the surveys. Overall, oncologists reported a lack of familiarity and need for additional education in the areas of immunology as well as implications for immuno-oncology agents. Less than 15% of oncologists reported being very familiar with the immune system while 72% of learners indicated a need for additional education on adaptive immune responses. In addition, only 7% and11% of oncologists reported being very familiar with the concepts of immune escape and check points, respectively. Over 60% of oncologists reported little familiarity with emerging immunotherapies for the treatment of metastatic solid tumors, and a majority did not have a firm understanding of how to assess a patient's response According to the Asian healthcare industry is witnessing a paradigm shift, skewed towards point-of-care diagnostics, cost-effective personalized medicine, and treatment modalities, which not only offers efficient early diagnosis, but also treats cancer conditions in order to moderate the healthcare cost and disease liability. Cancer/Tumor profiling is one such technology with the exact potential to transform cancer/tumor diagnostics and therapeutics in the healthcare industry.

About 12.7 million cancer cases and 7.6 million cancer deaths are estimated to have occurred in 2008 worldwide, with 56% of the cases and 64% of the deaths in the economically developing world. Breast cancer, the most common tumor in women, presents a high survival percentage: 83% of patients have survived this type of cancer after five years. Lung cancer is one of the most aggressive tumors and survival after five years is very low: only 10% of patients diagnosed with a malignant neoplasm survive for more than five years. Colorectal cancer (of the colon and rectum), the most common malignant tumor if we group men and women together, presents an average survival rate of 50-55% five years after diagnosis, meaning that half the patients survive this form of cancer. Prostate cancer, today the most common tumor in men, has an increasingly favorable prognosis, with a global survival rate of 76%, which is higher in young adults. Ovarian cancer presents a very varied prognosis depending on age: whilst 70% of the group between 15 and 44 years survives this form of cancer, this is the case for only 19% of those over 74 years-old.

This market research report evaluates the Asian market of cancer/tumor profiling by geography, applications, technologies, and section types. Additionally, the requirements market is divided into five segments, namely Personalized Medicine, Biomarker Discovery, Diagnostics, Prognosis and Research Submissions; the technologies section is divided into five segments, namely Next-Generation Sequencing, Quantitative PCR, FISH/CISH, Immunohistochemistry, and Microarray; and finally, the segment types is partitioned into four parts, namely Genomics, Metabolomics, Proteomics, and Epigenetics. Of the above-mentioned application fragments, modified medicine is the largest revenue segment and NGS is the potential revenue yielding technology.

The cancer/tumor describing market was valued at $13.30 billion in 2012. At the end of 2013, the market is estimated to be $14.99 billion and is poised to reach around $35 billion by 2018, growing at a CAGR of 18.50% from 2013 to 2018.

The global market for cancer/tumor reporting is expected to grow, backed by technological advancements, investments, and huge funds. The market is endorsing a trend towards the development of personalized medicine and point-of-care diagnostic tests for cancer. Additionally, the demand for safe and cost-effective drugs for the treatment of cancer (which can be fulfilled by cancer/tumor profiling therapeutics), will fuel the market growth. However, the market will also experience improvements in biomarker discovery and prognosis areas during the forecast period.

Asia-Pacific is the largest hub for cancer/tumor profiling market, accounting for the largest share, followed by China and Australia. Asia-Pacific and Europe are expected to grow at a steady pace. However, the North America market and few countries from the ROW region are expected to witness a boost in demand and are poised to register maximum growth over the next five years, owing to high incidence of cancers, affected population, and the increased purchasing power of patients.

Sessions/Tracks

ConferenceSeries Ltd welcomes you to attend the "International Conference on Oncology Nursing" which is going to be held on July 03-04, 2017 at Barcelona, SPAIN which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Track 1: General Issues in Oncology Nursing

Oncology nurses practice in a variety of environments which include acute care hospitals, private oncologists' offices, ambulatory care clinics, radiation therapy facilities, home healthcare agencies, and community agencies. However most of the adults treated for cancer in the USA live free of disease for many years, several survivors experience long lasting side effects and complications of treatment. While others encounter recurrence or new cancers that require further treatment. Most of the Medical experts can’t always predict if or when they might occur. Some effects might enhance or go away with time such as anemia.

International Conference on Antimicrobial agents & Chemotherapy, October 19-20, 2017 Atlanta, Georgia USA; International Conference on GastroIntestinal Cancer and Therapeutics, October 16-18, 2017 Baltimore USA; International Conference on Urologic Oncology, June 26-28, 2017 Baltimore USA; International Conference on Blood Cancer & Treatment, June 26-27, 2017 London UK; IMPAKT 2017 Breast Cancer Conference, May 04-06, 2017 Brussels, Belgium; ELCC 2017 European Lung Cancer Conference, May 05-08, 2017 Geneva, Switzerland; International Conference on Innovative Approaches in Head & Neck Oncology, March 16-18, 2017 Barcelona Spain; Immune Regulation in Autoimmunity and Cancer, March 26-30, 2017 Columbia Canada.

Societies: American Society of Clinical Oncology (ASCO), European School of Oncology (ESO), International Society of Geriatric Oncology (SIOG), International Association for the Study of Pain (IASP), Union for International Cancer Control (UICC), Society for Integrative Oncology (SIO), Asian Clinical Oncology Society (ACOS).

Track 2: Clinical Oncology Nursing

Organ/Tumor Specific Cancers are the cancers named based on the location of cancer in the body organs. Cancer may affect about every organ in the human body. Each type of cancer is different with its own causes, symptoms and the methods of treatment. Lung cancer was considered to be the most common cancer worldwide in men causing nearly 17% of the total number of new cases which were diagnosed in the year 2012 and became a crucial topic for World Cancer Conferences. Lung cancer which is also known as carcinoma of the lung or pulmonary carcinoma is a malignant lung tumor which is distinguished by uncontrolled cell growth in the tissues of the lung.

Track 3: Cancer Pain Management

The majority of people with cancer will experience pain at some time or another. The pain can result from the cancer itself, or from the cancer's treatment. In addition, some people who have been cured of their cancer can continue to suffer from pain. Cancer pain, or the discomfort that stems from cancer and its treatment, can be controlled most of the time, in which a nurse plays a important role. There are many different medicines and methods available to control cancer pain. People who have cancer and are feeling pain need to inform their doctor immediately. The earlier pain treatment is started, the more effective it may be.

Track 4: Cancer Immunotherapy & Stem Cell Therapy

This section in several oncology nursing conferences and oncology nursing meetings addresses the scope of the study which entails the current immunology therapeutics markets for several of the most common cancers. The sectors covered are colony stimulating factors (CSFs), interferon Alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Stem cell transplant (also called peripheral blood stem cell transplant) is a treatment to try to cure some types of cancer, such as leukemia, lymphoma and myeloma. You have very high doses of chemotherapy, sometimes with whole body radiotherapy.

Track 5: Cancer Prognosis

Prognosis is the outlook or the chance of recovery from cancer. New and better treatments are helping people diagnosed with breast cancer live longer than ever before. Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate. Oncology Cancer survival rates are supported on research from information gathered on hundreds or thousands of individuals with a particular cancer. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed terribly early and people diagnosed terribly late.

Track 6: Oncology Nursing Practice

Oncology has become one of the most important focus areas for pharmaceutical and biotech companies because of the high gear unmet need for improved handling for various types of Cancers. For an oncologist or an oncology nurse, to find the appropriate words to console a person who is suffering the loss of a loved one can be troublesome. This section in several oncology nursing conferences & oncology nursing meetings addresses how different groups of oncologists, patients, and Nurses think about the end-of-life care issues. This section discusses an oncologist's responsibility and perspective when it comes to subjects such as advanced cancer, hospice , do not resuscitate orders, cytotoxic therapy, maintaining a patient's dignity, supportive care and imminent decease.

Track 7: Complementary and Alternative Medicine (CAM)

Complementary and Alternative Medicine (CAM )is the term for medical products and practices that are not part of standard medical categories. Some CAM therapies have undergone careful evaluation and have found to be safe and effective. However there are others that have been found to be ineffective or possibly harmful. CAM therapies need to be evaluated with the same long and careful research process used to evaluate standard treatments. Standard cancer treatments have generally been studied for safety and effectiveness through an intense scientific process that includes clinical trials with large numbers of patients.

Track 8: Supportive Care Services & Lifestyle Connection

A cancer diagnosis and its treatment can be overwhelming. Usually patients and family members have many questions and concerns about the disease and the treatment. The supportive care program helps patients and family members deal with the physical and emotional distress caused by the cancer diagnosis and treatment. The less distress patients have, the more energy they can direct toward recovery. Comprehensive supportive care services require the expertise of an interdisciplinary team in order to adequately assess and treat the complex needs of cancer patients and their families.

Track 9: Cancer Therapy and Treatment

The landscape of Cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumor growth has ended. A complex scenario where the molecular features of tumors seem to be the cornerstone of any therapy is now emerging. Here we provide an overview on the different approaches to cancer treatment. This review will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanisms underpinning their efficacy. We briefly elaborate, finally, on new biomarkers development and how it should rule and determine the future of therapeutic research in cancer.

Track 10:Anti-Cancer Vaccines/drugs

Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Tissue-specific gene delivery using immune liposomes has also been achieved in brain, and breast cancer tissue. Antibody-directed enzyme pro drug therapy involves the application of cancer associated monoclonal antibodies which are linked to a drug-activating enzyme. A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers. However vaccines against some oncoviruses have proven extremely effective. Treatment often fails when cancer becomes resistant to anti-cancer drugs.

Track 11: Cancer Prognosis

Track 12: Cancer-Basic and Applied Research

Cancer Cell Biology, Diagnosis and Applied Research are using cell biological and other methods to investigate the mechanisms that regulate cell proliferation and differentiation. There is considerable interaction between individual laboratories in those areas. Cancer stem cells (CSCs) are cancer cells that possess characteristics associated with normal stem cells, the ability to give rise to all cell types found in a particular cancer sample. The process by which cancer cells spread to other parts of the body is also called metastasis. The metastasis of blood and lymphatic system cancers to the lung, central nervous system, heart and other tissues has been reported. Cancer is a multistep process involving several cell signaling pathways.

Past Conference Report

Oncology Nursing 2016

Past Reports Gallery

To Collaborate Scientific Professionals around the World

Conference Date July 03-04, 2017

For Sponsors & Exhibitors

sponsor@conferenceseries.com

Speaker Opportunity

Poster Opportunity E-Poster Opportunity

Useful Links

Past Conference Report

Oncology Nursing 2016 Gallery Oncology Nursing 2016 Conference

Supported By

Journal of Nursing & Care Journal of Integrative Oncology Journal of Clinical & Experimental Oncology

All accepted abstracts will be published in respective Conference Series International Journals.

Abstracts will be provided with Digital Object Identifier by

International Conference On Oncology Nursing

July 03-04, 2017 Barcelona, Spain

Caring is the Essence of Cancer Nursing

Conference Series Conferences gaining more Readers and Visitors

Renowned Speakers

Benedict Benigno

Wassil Nowicky

Jan Lewin

Sang Y Lee

Hiroshi Osawa

Niccola Funel

Recommended Global Nursing Webinars & Conferences

Europe & UK

Asia Pacific & Middle East

Canada

Euro Oncology Nursing 2017

About Conference

Market Analysis

Conference Highlights:

Why to attend???

A Unique Opportunity for Advertisers and Sponsors at this International event:

Sessions/Tracks

Past Conference Report

To Collaborate Scientific Professionals around the World

Useful Links

Past Conference Report

Supported By